Dibromo-Edaravone Induces Anti-Erythroleukemia Effects via the JAK2-STAT3 Signaling Pathway
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26094000 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Qiqing Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang 55001…. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Janus Kinase 2, Signal Transduction, Leukemia, Erythroblastic, Acute. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Department of Guizhou Province, Guizhou Provincial Basic Research Program (Natural Science).
Abstract (Originalsprache)
Acute erythroid leukemia (AEL) is a rare and aggressive hematological malignancy managed with chemotherapy, targeted therapies, and stem cell transplantation. However, these treatments often suffer from limitations such as refractoriness, high toxicity, recurrence, and drug resistance, underscoring the urgent need for novel therapeutic approaches. Dibromo-edaravone (D-EDA) is a synthetic derivative of edaravone (EDA) with unreported anti-leukemic properties. In this study, D-EDA demonstrated potent cytotoxicity against HEL cells with an IC50 value of 8.17 ± 0.43 μM using an MTT assay. Morphological analysis via inverted microscopy revealed reductions in cell number and signs of cellular crumpling and fragmentation. Flow cytometry analysis, Hoechst 33258 staining, Giemsa staining, a JC-1 assay, and a reactive oxygen species (ROS) assay showed that D-EDA induced apoptosis in HEL cells. Furthermore, D-EDA induced S-phase cell cycle arrest. Western blot analysis showed significant upregulation of key apoptosis-related proteins, including cleaved caspase-9, cleaved caspase-3, and cleaved poly ADP-ribose polymerase (PARP), alongside a reduction in Bcl-2 expression. Additionally, oncogenic markers such as c-Myc, CyclinA2, and CDK2 were downregulated, while the cell cycle inhibitor p21 was upregulated. Mechanistic studies involving molecular docking, a cellular thermal shift assay (CETSA), the caspase inhibitor Z-VAD-FMK, JAK2 inhibitor Ruxolitinib, and STAT3 inhibitor Stattic revealed that D-EDA activates the caspase cascade and inhibits the JAK2-STAT3 signaling pathway in HEL cells. In vivo, D-EDA improved spleen structure, increased the hemolysis ratio, and extended survival in a mouse model of acute erythroleukemia. In conclusion, D-EDA induces apoptosis via the caspase cascade and JAK2-STAT3 signaling pathway, demonstrating significant anti-leukemia effects in vitro and in vivo. Thus, D-EDA may be developed as a potential therapeutic agent for acute erythroleukemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang 550014, China.
- Natural Products Research Center of Guizhou Province, Guiyang 550014, China.
- College of Pharmacy, Guizhou Medical University, Guiyang 550004, China.
- School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China.
Förderung
- National Natural Science Foundation of China
- Science and Technology Department of Guizhou Province
- Guizhou Provincial Basic Research Program (Natural Science)
Zitieren
APA
Chen, Q., Liu, S., Wei, X., Zhao, P., Tian, F., Yang, K., Song, J., Huang, Y., Wen, M., Song, J., Jian, Y., & Li, Y. (2025). Dibromo-Edaravone Induces Anti-Erythroleukemia Effects via the JAK2-STAT3 Signaling Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094000
Vancouver
Chen Q, Liu S, Wei X, Zhao P, Tian F, Yang K, et al. Dibromo-Edaravone Induces Anti-Erythroleukemia Effects via the JAK2-STAT3 Signaling Pathway. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094000
BibTeX
@article{Chen2025,
author = {Chen, Qiqing and Liu, Sheng and Wei, Xuenai and Zhao, Peng and Tian, Fen and Yang, Kang and Song, Jingrui and Huang, Yubing and Wen, Min and Song, Jialei and Jian, Yong and Li, Yanmei},
title = {Dibromo-Edaravone Induces Anti-Erythroleukemia Effects via the JAK2-STAT3 Signaling Pathway},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26094000}
}
EUVIMED